Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<2.0
General Information
Version
4.10 (US
Revision date
2024-09-16
Product name
ELASTOSIL E60 N GREY
1.2.1 Relevant identified uses
Industrial Raw material for: elastomer products 1.2
Emergency telephone
(800) 424-9300, (703) 527-3887
Icons in SDS
Company Information
company name
Wacker Chemie AG
GHS Information
Signal word
H-Code
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GHS classification in accordance with the H-Code Serious eye damage/eye irritation, Category 2A H319 Skin corrosion/irritation, Category 2 H315
Signal word
H-Code
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. P-Code
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P305 + P351 + IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to P338 do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention.
2.3 Other hazards
The product hydrolyses under formation of acetic acid (CAS-No. 64-19-7). Acetic acid is classified concerning both physical and health hazards. The hydrolysis rate and consequently the relevance for the hazard profile of the product is strongly dependent on the specific conditions. Endocrine disrupting properties - human health: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties - environment: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
